Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

Berlin-based Quantune is trying to shrink laser spectrometers so that you can wear one on your wrist, and it just raised $9M ...

Dexcom Inc, a leader in continuous glucose monitoring technology, officially opened its first manufacturing facility outside ...

Continuous Glucose Monitoring (CGM) is transforming diabetes care in India, where the disease has reached alarming rates. Continuous Glucose Monitoring is truly a game-changer for diabetes management.

Operator: Good day, everyone, and welcome to the Senseonics Third Quarter 2024 Earnings Call. At this time, all participants ...

Let's first review what DexCom does. The company is a leader in the market for continuous glucose monitoring (CGM) systems, ...

Shares of SENS fell 2.5% to 34¢ apiece in pre-market trading today. The Germantown, Maryland-based implantable continuous glucose monitor (CGM) maker reported losses of $23.98 million. That equals 4¢ ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

New research presents a solution to a fundamental challenge: ensuring accurate glucose readings from wearable devices. Read more.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...